Densitas Announces the Commercial Release of intelliMaven™: The First GPT AI Companion to Elevate Mammography Quality Standards.

The market leader in Operational AI solutions will showcase its new GPT AI solution at the upcoming SBI symposium in Montreal.

HALIFAX, NS, April 3rd, 2024 – Densitas®, a global leader in artificial intelligence solutions for breast cancer screening, announces the commercial release of intelliMaven™, a groundbreaking GPT AI assistant for mammography quality. Together with Densitas’ flagship product intelliMammo®, intelliMaven™ provides scalable and sustainable quality assurance for mammography facilities to meet FDA MQSA EQUIP compliance and ACR accreditation requirements.

In an industry-first move, Densitas is revolutionizing the way technologists master their craft. intelliMaven™ offers bespoke recommendations that align with each technologist’s individual learning journey and training needs. This personalized feedback not only accelerates the skill enhancement process but also ensures technologists can refine their positioning techniques with unprecedented efficiency to improve diagnostic accuracy and the standard of patient care.

intelliMaven™ is designed to support sustainable high-value mammography service delivery at scale by streamlining workflows and fostering a culture of confidence and autonomy among technologists, unlocking new operational efficiencies with expert feedback in real time.

“IntelliMaven™ is a game-changer. Access to synchronous feedback based on continuous data collection sharpens technologists’ decision-making skills, allowing them greater independence and autonomy, therefore diminishing interruptions for radiologists,” said Dr. Georgia Spear, Chief Breast Imaging at Endeavor Health (Chicago, IL). “Its proficiency in analyzing complex data and summarizing it clearly and succinctly is truly remarkable. This ensures impartial and effective performance reviews. This software doesn’t just add value to daily operations; it redefines them.”

As mammography practices worldwide face an unprecedented staffing crisis, excessive workloads, and alarming burnout rates among technologists and radiologists, intelliMaven™ is poised to elevate mammography quality standards to:

• Save Time: by transforming complex data into actionable insights swiftly and in easily understood narrative reports, allowing care teams to prioritize patient care and other high-value activities.
• Optimize Radiologists’ Reading Efficiency: by offering immediate and continuous feedback to technologists regarding their performance, and shielding radiologists from frequent interruptions while reading mammograms.
• Mitigate Burnout: by reducing cognitive fatigue and easing decision-making pressures through the automation of data analysis and interpretation, and delivering real-time results and feedback in narrative language.

intelliMaven™ provides personalized, data-driven training guidance for technologists, paired with expert advice for ongoing skill enhancement in mammography techniques. It also delivers objective, standardized feedback to empower technologists, fostering greater ownership and autonomy in their roles and enhancing job satisfaction.

Discover how intelliMaven™ can transform your mammography practice at SBI Booth #415. Priority will be given to pre-booked demos. Book yours at https://densitashealth.com/sbi-2024/ 

About Densitas
Densitas® provides scalable Operational AI solutions for breast cancer screening, focusing on improving quality, operational efficiencies, and workflows. Our products standardize mammography positioning and breast density assessments, streamline compliance with MQSA EQUIP/ACR standards, and provide clinical care teams with actionable information through digitized workflows and evidence-based decision tools. For more information, visit www.densitashealth.com.